News & Publications

This study analyzed outcomes from the care of 8252 Merkel cell carcinoma patients at 1147 facilities in the US. It found that patients did better if cared for at higher volume / larger facilities. Such facilities tend to follow evidence-based guidelines, and are more likely to provide multi-discipli...

3 generations of mentor-mentees gather in Aomori Japan at the Japanese Society for Investigative Dermatology. DOM members Drs Masaoki Kawasumi, Tomoko Akaike, and Paul Nghiem, all gave plenary session talks. Left to right: Tomoko Akaike is a Japanese dermatologist doing a clinical research fe...

Parents are always looking out for their kids. It’s rare when it happens the other way around. But Susan Manber’s 13-year-old daughter saved her life. It happened one afternoon, not long after Hurricane Sandy had wreaked havoc on the New York City area. “We’d been without power for two weeks...

On September 9, 2019 in Seattle, over 280 patients, family members, clinicians, scientists, pharmaceutical partners, and trainees from across the United States gathered for the 14th annual Merkel cell carcinoma Dinner Meeting. The evening began with a bit of social gathering, beautiful music (vio...

Living with Merkel Cell Carcinoma is a free workshop series organized by CancerCare and can be attended over the phone or online. Part I of the series, Treatment Perspectives on Merkel Cell Carcinoma, will take place on November 15, 2019, 1:30-2:30 pm ET and will feature a panel of experts includ...

PLEASE NOTE: this site is in its early stages of development and the underlying predictive model has not yet been finalized or undergone peer review. If you have questions or feedback, please email aard@uw.edu Disclaimer: No Medical Advice. ALTHOUGH SOME CONTENT MAY BE PROVIDED BY INDIVIDU...

Merkel cell carcinoma (MCC) is an aggressive skin cancer that recurs in more than one-third of cases, with reported mortality rates of 33%to 46%.1 Given this high risk situation, MCC is often managed with therapies that are aggressive and potentially toxic: extensive surgery, radiation therapy (RT),...

In October 2017, a multidisciplinary symposium on new developments in the comprehensive management of Merkel cell carcinoma was held at the University of Rochester Medical Center. The event included specialists across many disciplines such as dermatology, surgical oncology, otolaryngology, radiation...

The fund supports patients who have been diagnosed with the rare form of skin cancer known as Merkel Cell Carcinoma (MCC). Once approved, the financial fund provides one-time assistance of $450 to cover transportation-related expenses connected to treatment appointments. Eligible patients include th...

BACKGROUND: Merkel cell carcinoma (MCC) is a rare and aggressive type of cancer with poor outcomes. OBJECTIVE: To describe treatment patterns, overall survival, and healthcare costs associated with advanced MCC (aMCC) using data from Medicare enrollees who received an aMCC diagnosis in the USA State...